IL111454A - The heterocyclic carboxamides are converted for use as pharmacy preparations, a number of such new compounds, and their preparation by the Government Printer Server Device, Patent Diary, p. - Google Patents
The heterocyclic carboxamides are converted for use as pharmacy preparations, a number of such new compounds, and their preparation by the Government Printer Server Device, Patent Diary, p.Info
- Publication number
- IL111454A IL111454A IL11145494A IL11145494A IL111454A IL 111454 A IL111454 A IL 111454A IL 11145494 A IL11145494 A IL 11145494A IL 11145494 A IL11145494 A IL 11145494A IL 111454 A IL111454 A IL 111454A
- Authority
- IL
- Israel
- Prior art keywords
- alkyl
- formula
- radical
- substituted
- carboxylic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4337271A DE4337271A1 (de) | 1993-11-02 | 1993-11-02 | Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel |
DE19944410881 DE4410881A1 (de) | 1994-03-29 | 1994-03-29 | Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel |
DE19944433928 DE4433928A1 (de) | 1994-09-23 | 1994-09-23 | Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel |
Publications (2)
Publication Number | Publication Date |
---|---|
IL111454A0 IL111454A0 (en) | 1994-12-29 |
IL111454A true IL111454A (en) | 2001-08-08 |
Family
ID=27205714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11145494A IL111454A (en) | 1993-11-02 | 1994-10-30 | The heterocyclic carboxamides are converted for use as pharmacy preparations, a number of such new compounds, and their preparation by the Government Printer Server Device, Patent Diary, p. |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0650961B1 (ja) |
JP (1) | JPH07228571A (ja) |
KR (1) | KR950014072A (ja) |
CN (1) | CN1107145A (ja) |
AT (1) | ATE149486T1 (ja) |
AU (1) | AU676775B2 (ja) |
CA (1) | CA2134866A1 (ja) |
CY (1) | CY2120B1 (ja) |
CZ (1) | CZ289356B6 (ja) |
DE (1) | DE59401924D1 (ja) |
DK (1) | DK0650961T3 (ja) |
ES (1) | ES2101421T3 (ja) |
GR (1) | GR3023174T3 (ja) |
HK (1) | HK1006711A1 (ja) |
IL (1) | IL111454A (ja) |
MY (1) | MY112413A (ja) |
NO (1) | NO301880B1 (ja) |
NZ (1) | NZ264821A (ja) |
PL (1) | PL179794B1 (ja) |
TW (1) | TW399046B (ja) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL135495A (en) * | 1995-09-28 | 2002-12-01 | Hoechst Ag | Intermediate compounds for the preparation of quinoline-converted amines - 2 - carboxylic acid |
DE19746287A1 (de) * | 1997-10-20 | 1999-04-22 | Hoechst Marion Roussel De Gmbh | Substituierte Isochinolin-2-Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel |
FR2803592A1 (fr) * | 2000-01-06 | 2001-07-13 | Aventis Cropscience Sa | Nouveaux derives de l'acide 3-hydroxypicolinique, leur procede de preparation et compositions fongicides les contenant. |
DE10123587B4 (de) * | 2001-05-08 | 2005-04-07 | Schering Ag | Cyanoanthranylamid-Derivate und deren Verwendung als Arzneimittel |
DE10123573B4 (de) * | 2001-05-08 | 2005-06-02 | Schering Ag | N-Oxidanthranylamid-Derivate und deren Verwendung als Arzneimittel |
DE50206476D1 (de) | 2001-05-08 | 2006-05-24 | Schering Ag | Cyanoanthranylamid-derivate und deren verwendung als arzneimittel |
CN101664553B (zh) * | 2001-12-06 | 2013-08-21 | 法布罗根股份有限公司 | 低氧诱导因子(HIF)α的稳定化 |
DK2289531T3 (en) | 2001-12-06 | 2018-10-01 | Fibrogen Inc | Medications for the treatment or prevention of anemia |
EP2295060B1 (en) | 2001-12-06 | 2018-10-31 | Fibrogen, Inc. | Treatment or prevention of ischemic or hypoxic conditions |
US7615565B2 (en) | 2002-07-31 | 2009-11-10 | Bayer Schering Pharma Aktiengesellschaft | VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines |
US8124582B2 (en) | 2002-12-06 | 2012-02-28 | Fibrogen, Inc. | Treatment of diabetes |
US7618940B2 (en) | 2002-12-06 | 2009-11-17 | Fibrogen, Inc. | Fat regulation |
US8614204B2 (en) | 2003-06-06 | 2013-12-24 | Fibrogen, Inc. | Enhanced erythropoiesis and iron metabolism |
CN103145616B (zh) | 2003-06-06 | 2015-09-30 | 菲布罗根有限公司 | 含氮杂芳基化合物及其在增加内源性促红细胞生成素中的用途 |
EP1657241A1 (en) | 2004-11-03 | 2006-05-17 | Schering Aktiengesellschaft | Novel anthranilamide pyridinureas as VEGF receptor kinase inhibitors |
US7906533B2 (en) | 2004-11-03 | 2011-03-15 | Bayer Schering Pharma Ag | Nicotinamide pyridinureas as vascular endothelial growth factor (VEGF) receptor kinase inhibitors |
EP1655295A1 (en) | 2004-11-03 | 2006-05-10 | Schering Aktiengesellschaft | Anthranilamide pyridinureas as VEGF receptor kinase inhibitors |
JP4792048B2 (ja) | 2005-03-02 | 2011-10-12 | ファイブロゲン インコーポレイティッド | チエノピリジン化合物およびその使用方法 |
CN101394843A (zh) * | 2005-06-06 | 2009-03-25 | 菲布罗根公司 | 使用HIFα稳定剂的改进的贫血治疗 |
WO2006138511A2 (en) | 2005-06-15 | 2006-12-28 | Fibrogen, Inc. | Use of hif 1alfa modulators for treatment of cancer |
AU2007211077B2 (en) | 2006-01-27 | 2012-09-20 | Fibrogen, Inc. | Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (HIF) |
BRPI0710527B8 (pt) | 2006-04-04 | 2021-05-25 | Fibrogen Inc | compostos de pirrolo- e tiazolo-piridina e composição farmacêutica que os compreende |
PL3026044T3 (pl) * | 2006-06-26 | 2019-04-30 | Akebia Therapeutics Inc | Inhibitory prolilo-hydroksylazy i sposoby ich użycia |
WO2009002533A1 (en) | 2007-06-27 | 2008-12-31 | The Brigham And Women's Hospital, Inc. | Inflammatory bowel disease therapies |
WO2009038759A2 (en) * | 2007-09-20 | 2009-03-26 | Amgen Inc. | 1-(4-(benzylbenzamid0) -benzyl) azetidine-3-carboxylic acid derivatives and related compounds as slp receptor modulators for the treatment of immune disorders |
CN102272117B (zh) | 2008-11-14 | 2015-06-17 | 菲布罗根有限公司 | 作为hif羟化酶抑制剂的苯并噻喃衍生物 |
KR101007674B1 (ko) * | 2010-08-13 | 2011-01-13 | 김병두 | 보조 캡이 부착된 고속용사 건 및 코팅장치 |
KR101007675B1 (ko) * | 2010-08-13 | 2011-01-13 | 김병두 | 보조 캡 이 부착된 플라즈마 용사 건 및 이를 활용하는 플라즈마 용사 시스템 |
NO2686520T3 (ja) | 2011-06-06 | 2018-03-17 | ||
SG11201405574UA (en) | 2012-03-09 | 2014-10-30 | Fibrogen Inc | 4 -hydroxy- isoquinoline compounds as hif hydroxylase inhibitors |
UA111542C2 (uk) | 2012-07-04 | 2016-05-10 | Агро-Канесьо Ко., Лтд. | Похідне складного ефіру 2-амінонікотинової кислоти та бактерицид, що містить зазначене похідне як активний інгредієнт |
US8883823B2 (en) | 2012-07-16 | 2014-11-11 | Fibrogen, Inc. | Crystalline forms of a prolyl hydroxylase inhibitor |
MX355428B (es) | 2012-07-16 | 2018-04-18 | Fibrogen Inc | Formas cristalinas del acido [ (4-hidroxi-1-metil-7-fenoxi-isoquin olin-3-carbonil) -amino] -acetico inhibidor de prolil hidroxilasa. |
AU2013290437B2 (en) | 2012-07-16 | 2017-11-02 | Fibrogen, Inc. | Process for making isoquinoline compounds |
AU2014209319B2 (en) | 2013-01-24 | 2018-04-19 | Fibrogen, Inc. | Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid |
KR20220164069A (ko) | 2013-06-06 | 2022-12-12 | 피브로겐, 인크. | Hif 하이드록실라제 억제자의 약학적 제형 |
DK3007695T3 (da) | 2013-06-13 | 2024-03-18 | Akebia Therapeutics Inc | Sammensætninger og fremgangsmåder til behandling af anæmi |
JP2016537365A (ja) | 2013-11-15 | 2016-12-01 | アケビア セラピューティクス インコーポレイテッドAkebia Therapeutics Inc. | {[5−(3−クロロフェニル)−3−ヒドロキシピリジン−2−カルボニル]アミノ}酢酸の固体形態、組成物、及びその使用 |
BR112017015852A2 (pt) | 2015-01-23 | 2018-03-27 | Akebia Therapeutics Inc | forma de cristal, sal hemicálcico, sal hemicálcico di-hidratado, sal monossódico hidratado, sal bissódico monoidratado, sal monossódico anidro e método para preparar o composto 1 |
CN106146395B (zh) * | 2015-03-27 | 2019-01-01 | 沈阳三生制药有限责任公司 | 3-羟基吡啶化合物、其制备方法及其制药用途 |
HRP20211862T1 (hr) | 2015-04-01 | 2022-03-04 | Akebia Therapeutics, Inc. | Pripravci za i postupci liječenja anemije |
AR114886A1 (es) | 2018-05-09 | 2020-10-28 | Akebia Therapeutics Inc | Proceso para preparar ácido 2-[[5-(3-clorofenil)-3-hidroxipiridin-2-carbonil]amino]acético |
BR112021004730A2 (pt) * | 2018-09-13 | 2021-06-01 | Kissei Pharmaceutical Co., Ltd. | composto de imidazopiridinona |
US11524939B2 (en) | 2019-11-13 | 2022-12-13 | Akebia Therapeutics, Inc. | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4015255A1 (de) | 1990-05-12 | 1991-11-14 | Hoechst Ag | Oxalyl-aminosaeurederivate, verfahren zu ihrer herstellung und ihrer verwendung als arzneimittel zur inhibierung der prolyl-hydroxylase |
EP0541042A1 (de) * | 1991-11-05 | 1993-05-12 | Hoechst Aktiengesellschaft | Pyridin-2,4- und 2,5-dicarbonsäureamide und deren Derivate, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel |
EP0633881B1 (en) * | 1992-03-11 | 2003-10-29 | Narhex Limited | Amine derivatives of oxo- and hydroxy-substitued hydrocarbons |
TW352384B (en) * | 1992-03-24 | 1999-02-11 | Hoechst Ag | Sulfonamido- or sulfonamidocarbonylpyridine-2-carboxamides, process for their preparation and their use as pharmaceuticals |
-
1994
- 1994-10-27 ES ES94117018T patent/ES2101421T3/es not_active Expired - Lifetime
- 1994-10-27 DK DK94117018.5T patent/DK0650961T3/da active
- 1994-10-27 EP EP94117018A patent/EP0650961B1/de not_active Expired - Lifetime
- 1994-10-27 AT AT94117018T patent/ATE149486T1/de not_active IP Right Cessation
- 1994-10-27 DE DE59401924T patent/DE59401924D1/de not_active Expired - Fee Related
- 1994-10-28 PL PL94305646A patent/PL179794B1/pl unknown
- 1994-10-30 IL IL11145494A patent/IL111454A/en not_active IP Right Cessation
- 1994-10-31 AU AU77564/94A patent/AU676775B2/en not_active Ceased
- 1994-10-31 NZ NZ264821A patent/NZ264821A/en unknown
- 1994-10-31 MY MYPI94002894A patent/MY112413A/en unknown
- 1994-11-01 CA CA002134866A patent/CA2134866A1/en not_active Abandoned
- 1994-11-01 CZ CZ19942683A patent/CZ289356B6/cs not_active IP Right Cessation
- 1994-11-01 NO NO944162A patent/NO301880B1/no not_active IP Right Cessation
- 1994-11-02 CN CN94117623A patent/CN1107145A/zh active Pending
- 1994-11-02 JP JP6292032A patent/JPH07228571A/ja not_active Abandoned
- 1994-11-02 KR KR1019940028871A patent/KR950014072A/ko not_active Application Discontinuation
- 1994-12-05 TW TW083111257A patent/TW399046B/zh not_active IP Right Cessation
-
1997
- 1997-04-18 GR GR970400831T patent/GR3023174T3/el unknown
-
1998
- 1998-06-22 HK HK98105872A patent/HK1006711A1/xx not_active IP Right Cessation
- 1998-09-29 CY CY9800039A patent/CY2120B1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP0650961A1 (de) | 1995-05-03 |
IL111454A0 (en) | 1994-12-29 |
AU676775B2 (en) | 1997-03-20 |
HK1006711A1 (en) | 1999-03-12 |
TW399046B (en) | 2000-07-21 |
NO944162L (no) | 1995-05-03 |
ES2101421T3 (es) | 1997-07-01 |
CY2120B1 (en) | 2002-04-26 |
EP0650961B1 (de) | 1997-03-05 |
JPH07228571A (ja) | 1995-08-29 |
NZ264821A (en) | 1997-02-24 |
CZ268394A3 (en) | 1995-05-17 |
NO301880B1 (no) | 1997-12-22 |
KR950014072A (ko) | 1995-06-15 |
PL179794B1 (pl) | 2000-10-31 |
DE59401924D1 (de) | 1997-04-10 |
PL305646A1 (en) | 1995-05-15 |
NO944162D0 (no) | 1994-11-01 |
CZ289356B6 (cs) | 2002-01-16 |
DK0650961T3 (da) | 1997-09-15 |
ATE149486T1 (de) | 1997-03-15 |
CN1107145A (zh) | 1995-08-23 |
MY112413A (en) | 2001-06-30 |
AU7756494A (en) | 1995-05-18 |
GR3023174T3 (en) | 1997-07-30 |
CA2134866A1 (en) | 1995-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL111454A (en) | The heterocyclic carboxamides are converted for use as pharmacy preparations, a number of such new compounds, and their preparation by the Government Printer Server Device, Patent Diary, p. | |
US5658933A (en) | Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals | |
US5620995A (en) | Substituted heterocyclic carboxyamides, their preparation and their use as pharmaceuticals | |
US5719164A (en) | Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates | |
US5610172A (en) | Sulfonamidocarbonylpyridine-2-carboxamides and pyridine-n-oxides which are useful as pharmaceuticals | |
US5792779A (en) | Pyridinone thrombin inhibitors | |
RU2129545C1 (ru) | Амиды сульфамидо- и сульфамидокарбонилпиридин-2-карбоновых кислот, способы их получения и фармацевтическая композиция | |
CA2245811A1 (en) | Pyridinone thrombin inhibitors | |
KR890001146B1 (ko) | 아미도-아미노산 및 그의 제조 방법 | |
CA2145473A1 (en) | Substituted heterocyclic carboxamidoesters their preparation and their use as pharmaceuticals | |
FI90767C (fi) | Menetelmä terapeuttisesti aktiivisten pyridiini-2,4- ja -2,5-dikarboksyylihappojohdannaisten valmistamiseksi | |
US5428046A (en) | Acylsulfonamido- and sulfonamidopyridine-2-carboxylic acid esters and their pyridine N-oxides, processes for their preparation and their use as medicaments | |
DE4433928A1 (de) | Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel | |
DE4434288A1 (de) | Substituierte heterocyclische Carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel | |
DE4410881A1 (de) | Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel | |
CA2145472A1 (en) | Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals | |
DE4337271A1 (de) | Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
MM9K | Patent not in force due to non-payment of renewal fees |